Organon & Co | OGN - Market Capitalization


Organon & Co reported $3.43B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Celltrion KRW 42.71T 908.1B May/2026
Cspc Pharmaceutical CNY 87.29B 19.74B Dec/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Merck USD 297.1B 35.84B Mar/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pharma Mar EUR 1.79B 211.96M May/2026
Qiagen NV USD 6.43B 1.85B May/2026
Sartorius EUR 14.25B 2.16B Mar/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025